Painful Diabetic Neuropathy
Study Name: Painful Diabetic Neuropathy
Clinics: Barnsley, Blackpool, Cannock, Leeds, Liverpool, Manchester and Teesside
Therapy Area: Diabetic Neuropathy
Gender and Age: Male and female (of non-childbearing potential) aged between 18 and 80
MAC is currently conducting a trial to test a new potential treatment for painful diabetic neuropathy (PDN). Diabetic neuropathy is the most common long-term complication of diabetes and is often experienced in terms of a burning, stabbing, pricking or aching sensation that is chronic and difficult to manage. The condition carries a substantial physical, social, and economic burden.
The trial medication aims to relieve or improve the pain experienced from diabetic neuropathy. The trial medication is also currently under investigation for use in other painful conditions. The medication or placebo will be administered intravenously, 6 times in total over 12 weeks of the 25-week trial period and is being developed to address the existing unmet need for an effective and safe treatment for this condition.
Key Inclusion Criteria
Men and women (of non-childbearing potential) aged between 18 and 80
Must have had painful diabetic neuropathy, beginning in both feet, for at least the past 6 months
Pain not adequately controlled with current treatments
Key Exclusion Criteria
An uncontrolled or unstable medical condition
The use of anti-inflammatory medication during the trial e.g. ibuprofen, naproxen and any anti-inflammatory cream or gel etc.
Other eligibility criteria will apply. Please contact MAC for more information.
Any other information
Eligible patients will receive a comprehensive health screen and study participation will be in collaboration with the patient’s treating physician.